Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey

Sponsor

University of Rome Tor Vergata (Other)

Overall Status

Completed

CT.gov ID

NCT04344197

Collaborator

(none)

1,200

Enrollment

Location

Actual Duration (Days)

2809.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

a brief questionnaire to get a clearer picture of the situation regarding surgical patients with special emphasis on asymptomatic Covid-19 patients.

Condition or Disease	Intervention/Treatment	Phase
Surgery COVID Asymptomatic Patient Covid-19 Preventive Measures	Other: global survey

Detailed Description

With new evidence on the role of asymptomatic patients in spreading the disease during the Covid-19 pandemic, symptom driven guidelines for testing, hospital allocation and personal protective equipment (PPE) use do not seem appropriate to limit in-hospital transmission. At time when lockdowns are in place in most countries, hospitals can become the new source of infection.

Guidelines are very variable depending on local policies and availability of medical supplies, resulting in most hospitals taking different preventive measures.

Study Design

Study Type:

Observational

Actual Enrollment :

1200 participants

Observational Model:

Other

Time Perspective:

Cross-Sectional

Official Title:

Surgery During Covid-19: The Role of Asymptomatic Patients, a Survey

Actual Study Start Date :

Apr 2, 2020

Actual Primary Completion Date :

Apr 8, 2020

Actual Study Completion Date :

Apr 15, 2020

Outcome Measures

Primary Outcome Measures

overview of surgical management on preventive measures of hospital infection spread during covid 19 [2/04/2020 to 15/04/2020]

Secondary Outcome Measures

testing policies and preventive measures for Covid-19, and their association with asymptomatic cases. [02/04/2020 to 15/04/2020]

Eligibility Criteria

Criteria

Ages Eligible for Study:

N/A and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

general surgeon

Exclusion Criteria:

other speciality

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Tor Vergata Hospital	Rome		Italy	00133

Sponsors and Collaborators

University of Rome Tor Vergata

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

Responsible Party:

Giuseppe Sigismondo Sica, Associate Professor, Head of Department, University of Rome Tor Vergata

ClinicalTrials.gov Identifier:

NCT04344197

Other Study ID Numbers:

s-covid survey

First Posted:

Apr 14, 2020

Last Update Posted:

Dec 29, 2020

Last Verified:

Dec 1, 2020

Individual Participant Data (IPD) Sharing Statement:

Undecided

Plan to Share IPD:

Undecided

Studies a U.S. FDA-regulated Drug Product:

Studies a U.S. FDA-regulated Device Product:

Additional relevant MeSH terms:

COVID-19

Study Results

No Results Posted as of Dec 29, 2020